{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:19:11Z","timestamp":1774981151893,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Clinical Specialist Construction Project","award":["Grant No. ZK108000"],"award-info":[{"award-number":["Grant No. ZK108000"]}]},{"name":"National Key Research and Development Program of China","award":["Grant No. 2022YFC3602103"],"award-info":[{"award-number":["Grant No. 2022YFC3602103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03925-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:51:50Z","timestamp":1745916710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CA19-9\/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Wenfeng","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"4","key":"3925_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00535-019-01658-7","volume":"55","author":"A Masamune","year":"2020","unstructured":"Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020;55(4):462\u201370.","journal-title":"J Gastroenterol"},{"key":"3925_CR2","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.jaut.2023.103121","volume":"140","author":"Y Li","year":"2023","unstructured":"Li Y, Song H, Meng X, Li R, Leung PSC, Gershwin ME, et al. Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review. J Autoimmun. 2023;140:103121.","journal-title":"J Autoimmun"},{"issue":"1","key":"3925_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gtc.2015.10.005","volume":"45","author":"K Madhani","year":"2016","unstructured":"Madhani K, Farrell JJ. Autoimmune pancreatitis: an update on diagnosis and management. Gastroenterol Clin North Am. 2016;45(1):29\u201343.","journal-title":"Gastroenterol Clin North Am"},{"issue":"12","key":"3925_CR4","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.1007\/s00330-023-09959-5","volume":"33","author":"SB Yoon","year":"2023","unstructured":"Yoon SB, Jeon TY, Moon SH, Shin DW, Lee SM, Choi MH, et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 2023;33(12):9010\u201321.","journal-title":"Eur Radiol"},{"issue":"3","key":"3925_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/den.14076","volume":"34","author":"A Kanno","year":"2022","unstructured":"Kanno A, Miwata T, Nagai H, Ikeda E, Ando K, Kawasaki Y, et al. Endoscopic ultrasound-guided pancreatic sampling for the histopathological diagnosis of autoimmune pancreatitis. Dig Endosc. 2022;34(3):420\u20137.","journal-title":"Dig Endosc"},{"key":"3925_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2016.10.046","volume":"385","author":"G Luo","year":"2017","unstructured":"Luo G, Liu C, Guo M, Long J, Liu Z, Xiao Z, et al. CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype. Cancer Lett. 2017;385:46\u201350.","journal-title":"Cancer Lett"},{"issue":"38","key":"3925_CR7","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.3748\/wjg.v12.i38.6225","volume":"12","author":"T Kamisawa","year":"2006","unstructured":"Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N, Tsuruta K, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol. 2006;12(38):6225\u20138.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3925_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.21037\/hbsn-23-436","volume":"12","author":"Z Yan","year":"2023","unstructured":"Yan Z, Chang X, Bai X, Han X, Feng Y, Yang A. Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma. Hepatobiliary Surg Nutr. 2023;12(6):997\u20131000.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"12","key":"3925_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/jgh.15163","volume":"35","author":"T Ishikawa","year":"2020","unstructured":"Ishikawa T, Kawashima H, Ohno E, Iida T, Suzuki H, Uetsuki K, et al. Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients. J Gastroenterol Hepatol. 2020;35(12):2281\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"3925_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cgh.2009.04.020","volume":"7","author":"ST Chari","year":"2009","unstructured":"Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7(10):1097\u2013103.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"3925_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4240\/wjgs.v12.i12.468","volume":"12","author":"T Lee","year":"2020","unstructured":"Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19\u2013\u20099 - tumor marker: past, present, and future. World J Gastrointest Surg. 2020;12(12):468\u201390.","journal-title":"World J Gastrointest Surg"},{"issue":"3","key":"3925_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1309\/H52VET3M6P7GYWG1","volume":"127","author":"SL La\u2019ulu","year":"2007","unstructured":"La\u2019ulu SL, Roberts WL. Performance characteristics of five automated CA 19\u2013\u20099 assays. Am J Clin Pathol. 2007;127(3):436\u201340.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"3925_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3349\/ymj.2013.54.3.643","volume":"54","author":"KJ Lee","year":"2013","unstructured":"Lee KJ, Yi SW, Chung MJ, Park SW, Song SY, Chung JB, Park JY. Serum CA 19\u2013\u20099 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei Med J. 2013;54(3):643\u20139.","journal-title":"Yonsei Med J"},{"issue":"2","key":"3925_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/bjc.1986.35","volume":"53","author":"C Haglund","year":"1986","unstructured":"Haglund C, Roberts PJ, Kuusela P, Scheinin TM, M\u00e4kel\u00e4 O, Jalanko H. Evaluation of CA 19\u2013\u20099 as a serum tumour marker in pancreatic cancer. Br J Cancer. 1986;53(2):197\u2013202.","journal-title":"Br J Cancer"},{"issue":"2","key":"3925_CR15","first-page":"105","volume":"3","author":"UK Ballehaninna","year":"2012","unstructured":"Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19\u2013\u20099 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3(2):105\u201319.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"3925_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","volume":"20","author":"Q Li","year":"2022","unstructured":"Li Q, Feng Z, Miao R, Liu X, Liu C, Liu Z. Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution. World J Surg Oncol. 2022;20(1):11.","journal-title":"World J Surg Oncol"},{"issue":"6446","key":"3925_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aaw3145","volume":"364","author":"DD Engle","year":"2019","unstructured":"Engle DD, Tiriac H, Rivera KD, Pommier A, Whalen S, Oni TE, et al. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science. 2019;364(6446):1156\u201362.","journal-title":"Science"},{"issue":"1","key":"3925_CR18","doi-asserted-by":"publisher","first-page":"8820","DOI":"10.1038\/s41598-020-65720-8","volume":"10","author":"S Kim","year":"2020","unstructured":"Kim S, Park BK, Seo JH, Choi J, Choi JW, Lee CK, et al. Carbohydrate antigen 19\u2013\u20099 elevation without evidence of malignant or pancreatobiliary diseases. Sci Rep. 2020;10(1):8820.","journal-title":"Sci Rep"},{"key":"3925_CR19","doi-asserted-by":"crossref","unstructured":"Bertino G, Ardiri AM, Calvagno GS, Malaguarnera G, Interlandi D, Vacante M et al. Carbohydrate 19.9 antigen serum levels in liver disease. Biomed Res Int. 2013; 2013:531640.","DOI":"10.1155\/2013\/531640"},{"issue":"3","key":"3925_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/172460080001500304","volume":"15","author":"E Giannini","year":"2000","unstructured":"Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Cholestasis is the main determinant of abnormal CA 19\u2013\u20099 levels in patients with liver cirrhosis. Int J Biol Markers. 2000;15(3):226\u201330.","journal-title":"Int J Biol Markers"},{"issue":"8","key":"3925_CR21","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1572-0241.2007.01264.x","volume":"102","author":"A Ghazale","year":"2007","unstructured":"Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3925_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pan.2014.07.010","volume":"14","author":"MC Chang","year":"2014","unstructured":"Chang MC, Liang PC, Jan S, Yang CY, Tien YW, Wei SC, et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14(5):366\u201372.","journal-title":"Pancreatology"},{"issue":"4","key":"3925_CR23","doi-asserted-by":"publisher","first-page":"e0174735","DOI":"10.1371\/journal.pone.0174735","volume":"12","author":"T Yan","year":"2017","unstructured":"Yan T, Ke Y, Chen Y, Xu C, Yu C, Li Y. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19\u2013\u20099, Globulin, eosinophils and hemoglobin. PLoS ONE. 2017;12(4):e0174735.","journal-title":"PLoS ONE"},{"issue":"5","key":"3925_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/ejso.1999.0925","volume":"26","author":"DV Mann","year":"2000","unstructured":"Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26(5):474\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3925_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21037\/gs.2015.11.02","volume":"5","author":"AO Omiyale","year":"2016","unstructured":"Omiyale AO. Autoimmune pancreatitis. Gland Surg. 2016;5(3):318\u201326.","journal-title":"Gland Surg"},{"issue":"1","key":"3925_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2006.10.007","volume":"140","author":"CM Kang","year":"2007","unstructured":"Kang CM, Kim JY, Choi GH, Kim KS, Choi JS, Lee WJ, Kim BR. The use of adjusted preoperative CA 19\u2013\u20099 to predict the recurrence of resectable pancreatic cancer. J Surg Res. 2007;140(1):31\u20135.","journal-title":"J Surg Res"},{"issue":"10","key":"3925_CR27","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.7150\/jca.25093","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu W, Liu Q, Wang W, Wang P, Chen J, Hong T, et al. Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant. J Cancer. 2018;9(10):1804\u201312.","journal-title":"J Cancer"},{"key":"3925_CR28","doi-asserted-by":"crossref","unstructured":"Xiao J, Wang L, Hong T, Li B, Liu W, Qu Q et al. The Prognostic Value of the CA19-9\/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study. J Oncol. 2021; 2021:5829893.","DOI":"10.1155\/2021\/5829893"},{"issue":"7","key":"3925_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.dld.2021.11.013","volume":"54","author":"J Ha","year":"2022","unstructured":"Ha J, Choi SH, Kim KW, Kim JH, Kim HJ. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Dig Liver Dis. 2022;54(7):849\u201356.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"3925_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40644-020-00324-z","volume":"20","author":"W Schima","year":"2020","unstructured":"Schima W, B\u00f6hm G, R\u00f6sch CS, Klaus A, F\u00fcgger R, Kopf H. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Cancer Imaging. 2020;20(1):52.","journal-title":"Cancer Imaging"},{"issue":"12","key":"3925_CR31","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s00330-018-5565-1","volume":"28","author":"S Lee","year":"2018","unstructured":"Lee S, Kim JH, Kim SY, Byun JH, Kim HJ, Kim MH, et al. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Eur Radiol. 2018;28(12):5267\u201374.","journal-title":"Eur Radiol"},{"issue":"12","key":"3925_CR32","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1007\/s00261-019-02155-4","volume":"44","author":"K Beker","year":"2019","unstructured":"Beker K, Lee KS, Tsai LL, Hegazi T, Garces-Descovich A, Brook A, Mortele KJ. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic Pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, Corona, and attraction signs. Abdom Radiol (NY). 2019;44(12):4048\u201356.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"3925_CR33","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1055\/a-1293-7279","volume":"9","author":"A Facciorusso","year":"2021","unstructured":"Facciorusso A, Barresi L, Cannizzaro R, Antonini F, Triantafyllou K, Tziatzios G, et al. Diagnostic yield of endoscopic ultrasound-guided tissue acquisition in autoimmune pancreatitis: a systematic review and meta-analysis. Endosc Int Open. 2021;9(1):E66\u201375.","journal-title":"Endosc Int Open"},{"issue":"7","key":"3925_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/den.13866","volume":"33","author":"SB Yoon","year":"2021","unstructured":"Yoon SB, Moon SH, Song TJ, Kim JH, Kim MH. Endoscopic ultrasound-guided fine needle aspiration versus biopsy for diagnosis of autoimmune pancreatitis: systematic review and comparative meta-analysis. Dig Endosc. 2021;33(7):1024\u201333.","journal-title":"Dig Endosc"},{"issue":"4","key":"3925_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jasc.2015.01.006","volume":"4","author":"G Cai","year":"2015","unstructured":"Cai G, Bernstein J, Aslanian HR, Hui P, Chhieng D. Endoscopic ultrasound-guided fine-needle aspiration biopsy of autoimmune pancreatitis: diagnostic clues and pitfalls. J Am Soc Cytopathol. 2015;4(4):211\u20137.","journal-title":"J Am Soc Cytopathol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03925-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:51:54Z","timestamp":1745916714000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03925-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3925"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03925-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines laid down in the Declaration of Helsinki. This study was approved by the Institutional Review Board of the Peking Union Medical College Hospital and was granted an exemption from the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}